Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a

Introduction : Pregnant women negative for human platelet antigen 1 a (HPA-1a) are at risk of alloimmunization with fetal HPA-1a antigen inherited from the father, and their offspring may develop fetal and neonatal alloimmune thrombocytopenia (FNAIT). The aim of this study was to analyze the freque...

Full description

Bibliographic Details
Main Authors: Marzena Dębska, Małgorzata Uhrynowska, Katarzyna Guz, Izabella Kopeć, Elżbieta Lachert, Agnieszka Orzińska, Piotr Kretowicz, Jolanta Antoniewicz-Papis, Romuald Dębski, Magdalena Łętowska, Anne Husebekk, Ewa Brojer
Format: Article
Language:English
Published: Termedia Publishing House 2016-11-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.termedia.pl/Identification-and-follow-up-of-pregnant-women-with-platelet-type-human-platelet-antigen-HPA-1bb-alloimmunized-with-fetal-HPA-1a,19,28681,1,1.html
_version_ 1817995494629048320
author Marzena Dębska
Małgorzata Uhrynowska
Katarzyna Guz
Izabella Kopeć
Elżbieta Lachert
Agnieszka Orzińska
Piotr Kretowicz
Jolanta Antoniewicz-Papis
Romuald Dębski
Magdalena Łętowska
Anne Husebekk
Ewa Brojer
author_facet Marzena Dębska
Małgorzata Uhrynowska
Katarzyna Guz
Izabella Kopeć
Elżbieta Lachert
Agnieszka Orzińska
Piotr Kretowicz
Jolanta Antoniewicz-Papis
Romuald Dębski
Magdalena Łętowska
Anne Husebekk
Ewa Brojer
author_sort Marzena Dębska
collection DOAJ
description Introduction : Pregnant women negative for human platelet antigen 1 a (HPA-1a) are at risk of alloimmunization with fetal HPA-1a antigen inherited from the father, and their offspring may develop fetal and neonatal alloimmune thrombocytopenia (FNAIT). The aim of this study was to analyze the frequency of HPA-1a alloimmunization in pregnant Polish women, the feasibility of using maternal platelets for intrauterine transfusions in women subjected to diagnostic fetal blood sampling (FBS) and to discuss potential consequences of alloimmunization. Material and methods : Fifteen thousand two hundred and four pregnant women were typed for HPA-1a; HPA-1a negative were screened for anti-HPA-1a. Alloimmunized women received specialist perinatology care; some of them were subjected to FBS, followed by transfusion of HPA-1a negative platelet concentrates (PC) prepared from maternal blood. Results : Three hundred seventy-three (2.5%) women were HPA-1a negative, and 32 (8.6%) tested positively for anti-HPA-1a. Antibodies were detected in 22 women during pregnancy. Diagnostic FBS followed by PC transfusion was performed in 14 woman, who were platelet donors for their 16 unborn babies. Blood donations were tolerated well by the patients, and also intrauterine platelet transfusions were uneventful. Pharmacotherapy with intravenous immunoglobulins was implemented in 11/22 patients. Conclusions : HPA-1a negative women (ca. 2.5% of all pregnant patients) are at risk of alloimmunization with HPA-1a antigen and developing FNAIT. Alloimmunized women can be donors of platelets for their offspring providing removal of antibodies from PC. Owing to potential complications, special care should be taken if an alloimmunized woman was qualified as a blood or stem cell recipient.
first_indexed 2024-04-14T02:06:43Z
format Article
id doaj.art-4584c56eca31439fb15b493379270a80
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-04-14T02:06:43Z
publishDate 2016-11-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-4584c56eca31439fb15b493379270a802022-12-22T02:18:37ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512016-11-011451041104710.5114/aoms.2016.6360028681Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1aMarzena DębskaMałgorzata UhrynowskaKatarzyna GuzIzabella KopećElżbieta LachertAgnieszka OrzińskaPiotr KretowiczJolanta Antoniewicz-PapisRomuald DębskiMagdalena ŁętowskaAnne HusebekkEwa BrojerIntroduction : Pregnant women negative for human platelet antigen 1 a (HPA-1a) are at risk of alloimmunization with fetal HPA-1a antigen inherited from the father, and their offspring may develop fetal and neonatal alloimmune thrombocytopenia (FNAIT). The aim of this study was to analyze the frequency of HPA-1a alloimmunization in pregnant Polish women, the feasibility of using maternal platelets for intrauterine transfusions in women subjected to diagnostic fetal blood sampling (FBS) and to discuss potential consequences of alloimmunization. Material and methods : Fifteen thousand two hundred and four pregnant women were typed for HPA-1a; HPA-1a negative were screened for anti-HPA-1a. Alloimmunized women received specialist perinatology care; some of them were subjected to FBS, followed by transfusion of HPA-1a negative platelet concentrates (PC) prepared from maternal blood. Results : Three hundred seventy-three (2.5%) women were HPA-1a negative, and 32 (8.6%) tested positively for anti-HPA-1a. Antibodies were detected in 22 women during pregnancy. Diagnostic FBS followed by PC transfusion was performed in 14 woman, who were platelet donors for their 16 unborn babies. Blood donations were tolerated well by the patients, and also intrauterine platelet transfusions were uneventful. Pharmacotherapy with intravenous immunoglobulins was implemented in 11/22 patients. Conclusions : HPA-1a negative women (ca. 2.5% of all pregnant patients) are at risk of alloimmunization with HPA-1a antigen and developing FNAIT. Alloimmunized women can be donors of platelets for their offspring providing removal of antibodies from PC. Owing to potential complications, special care should be taken if an alloimmunized woman was qualified as a blood or stem cell recipient.https://www.termedia.pl/Identification-and-follow-up-of-pregnant-women-with-platelet-type-human-platelet-antigen-HPA-1bb-alloimmunized-with-fetal-HPA-1a,19,28681,1,1.htmlHPA-1a cohort study anti-human platelet antigen 1a antibodies fetal/neonatal alloimmune thrombocytopenia platelet transfusions
spellingShingle Marzena Dębska
Małgorzata Uhrynowska
Katarzyna Guz
Izabella Kopeć
Elżbieta Lachert
Agnieszka Orzińska
Piotr Kretowicz
Jolanta Antoniewicz-Papis
Romuald Dębski
Magdalena Łętowska
Anne Husebekk
Ewa Brojer
Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a
Archives of Medical Science
HPA-1a cohort study
anti-human platelet antigen 1a antibodies
fetal/neonatal alloimmune thrombocytopenia
platelet transfusions
title Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a
title_full Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a
title_fullStr Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a
title_full_unstemmed Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a
title_short Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a
title_sort identification and follow up of pregnant women with platelet type human platelet antigen hpa 1bb alloimmunized with fetal hpa 1a
topic HPA-1a cohort study
anti-human platelet antigen 1a antibodies
fetal/neonatal alloimmune thrombocytopenia
platelet transfusions
url https://www.termedia.pl/Identification-and-follow-up-of-pregnant-women-with-platelet-type-human-platelet-antigen-HPA-1bb-alloimmunized-with-fetal-HPA-1a,19,28681,1,1.html
work_keys_str_mv AT marzenadebska identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT małgorzatauhrynowska identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT katarzynaguz identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT izabellakopec identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT elzbietalachert identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT agnieszkaorzinska identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT piotrkretowicz identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT jolantaantoniewiczpapis identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT romualddebski identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT magdalenałetowska identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT annehusebekk identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a
AT ewabrojer identificationandfollowupofpregnantwomenwithplatelettypehumanplateletantigenhpa1bballoimmunizedwithfetalhpa1a